Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Read Article
News
2024
2023
Archive
Search news articles
July 31, 2018
Promotions and team expansion!
August 1, 2018
CRINETICS PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
July 31, 2018
NOHLA ANNOUNCES THE HIRING OF DR. SARAH NOONBERG AS CMO AND APPOINTMENT OF DR. COLLEEN DELANEY AS CSO
July 16, 2018
Nohla Therapeutics Receives FDA Orphan Drug Designation for Dilanubicel for Hematopoietic Stem Cell Transplant Patients
July 12, 2018
Nohla Therapeutics Announces Second Closing of $56 Million Series B Financing
July 10, 2018
Rare endocrine disease biotech Crinetics Pharmaceuticals sets terms for $80 million IPO
June 26, 2018
NodThera secures £28 million ($40 million) Series A Financing
June 26, 2018
ZEMDRI (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections (cUTI)
June 23, 2018
IMPEL NEUROPHARMA ANNOUNCES FDA CLEARANCE OF IND FOR PIVOTAL PHASE 3 STUDY OF INP104 FOR ACUTE TREATMENT OF MIGRAINE
June 21, 2018
Crinetics Pharmaceuticals Awarded up to $3.2 Million in SBIR Grants for Congenital Hyperinsulinism and Acromegaly
« Previous Page
1
…
3
4
5
6
7
…
10
Next Page »